BIO-key International (BKYI) stock price, revenue, and financials

BIO-key International market cap is $9.5 m, and annual revenue was $4.04 m in FY 2018

$9.5 M

BKYI Mkt cap, 16-Oct-2019

$728.4 K

BIO-key International Revenue Q2, 2019
BIO-key International Net income (Q2, 2019)-1.4 M
BIO-key International EBIT (Q2, 2019)-1.3 M
BIO-key International Cash, 30-Jun-2019687 K

BIO-key International Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

5.3m6.3m4.0m

Cost of goods sold

145.7k260.4k216.5k439.3k

Gross profit

5.0m5.9m

Gross profit Margin, %

95%93%

General and administrative expense

2.8m4.1m4.4m5.7m5.3m

Operating expense total

2.8m4.1m4.4m7.3m6.7m

EBIT

(2.5m)(1.7m)(4.2m)(4.3m)(6.9m)

EBIT margin, %

(32%)(68%)(170%)

Interest expense

136.5k192.2k

Interest income

7.014.030.027.080.0

Income tax expense

(2.8k)(912.0)

Net Income

(2.6m)(1.9m)(4.2m)(4.3m)(6.9m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

669.8k430.6k415.8k431.5k942.4k841.5k748.1k739.8k551.6k728.4k

Cost of goods sold

47.5k39.2k113.1k144.2k67.1k30.3k55.8k66.6k46.3k38.8k55.7k190.9k

Gross profit

639.6k374.8k349.2k385.2k751.5k

Gross profit Margin, %

95%87%84%89%80%

General and administrative expense

740.7k857.0k895.1k989.5k1.0m1.0m991.6k1.0m925.9k1.6m1.4m1.2m1.5m1.1m1.0m1.4m1.1m

Operating expense total

740.7k1.3m895.1k989.5k1.0m1.0m1.5m1.0m925.9k2.1m1.9m1.2m1.9m1.4m1.4m1.8m1.4m

Depreciation and amortization

33.5k

EBIT

(765.7k)(93.4k)(1.1m)(274.6k)(937.9k)(1.1m)(1.2m)(1.3m)(1.2m)(1.4m)(1.8m)(1.6m)(2.2m)(1.7m)(1.6m)(1.8m)(1.3m)

EBIT margin, %

(162%)(270%)(319%)(277%)(170%)(261%)(221%)(222%)(327%)(180%)

Interest expense

13.9k20.0k114.9k

Interest income

2.02.02.02.01.06.07.06.06.08.06.06.014.044.070.054.0

Income tax expense

(912.0)(800.0)(912.0)(912.0)

Net Income

(782.6k)(299.2k)(1.0m)(51.5k)(924.1k)(1.1m)(1.2m)(1.4m)(1.1m)(1.4m)(1.8m)(1.6m)(2.2m)(1.7m)(1.6m)(1.8m)(1.4m)

BIO-key International Balance Sheet

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

2.0m4.3m1.1m288.7k323.9k

Accounts Receivable

284.0k3.4m1.6m2.9m1.6m

Inventories

9.4k348.6k465.4k946.8k998.8k

Current Assets

2.4m13.2m4.9m7.0m4.2m

PP&E

125.1k63.9k181.2k148.6k

Total Assets

2.7m20.4m17.3m16.1m11.7m

Accounts Payable

540.9k1.2m466.8k499.2k481.3k

Dividends Payable

401.3k

Current Liabilities

1.4m2.3m1.8m2.3m1.2m

Total Liabilities

1.7m2.3m1.8m2.3m1.2m

Preferred Stock

9.09.06.0

Additional Paid-in Capital

55.9m76.8m78.3m80.8m85.6m

Retained Earnings

(54.9m)(58.6m)(62.8m)(67.1m)(75.1m)

Total Equity

9.015.5m13.8m10.5m

Financial Leverage

2.3 m x1.1 x1.2 x1.1 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

225.3k592.9k517.8k167.2k303.5k282.4k72.2k3.5m2.0m177.4k1.2m988.3k971.9k1.3m304.0k1.0m459.3k687.0k

Accounts Receivable

562.5k847.9k562.3k305.2k491.7k653.5k740.4k689.9k

Inventories

5.7k8.9k22.2k12.0k205.4k412.6k150.7k458.9k480.0k568.2k571.0k567.2k879.6k899.2k930.5k1.0m980.9k1.0m

Current Assets

384.5k2.0m1.0m913.1k1.2m2.4m2.4m11.4m9.9m3.3m4.4m4.7m5.0m5.5m4.7m5.9m3.6m3.8m

PP&E

29.4k118.6k110.5k84.3k73.5k71.6k91.1k79.1k60.0k153.5k186.9k193.0k189.4k170.0k152.7k137.5k

Total Assets

705.5k2.3m1.3m1.2m1.5m2.7m2.7m18.6m17.1m15.5m15.6m15.4m15.0m14.1m12.6m13.0m11.3m11.2m

Accounts Payable

441.8k323.8k352.1k457.3k415.8k869.1k1.3m628.6k696.4k550.8k153.7k333.6k507.9k253.0k330.4k369.8k472.6k864.9k

Dividends Payable

200.6k200.6k601.9k802.5k

Current Liabilities

1.2m1.2m1.2m1.4m1.5m1.9m2.9m1.7m1.7m1.3m1.6m2.0m1.7m1.5m1.1m1.2m1.7m2.7m

Non-Current Liabilities

497.3k419.2k383.0k

Total Liabilities

1.7m1.6m1.5m1.9m2.9m1.7m1.7m1.3m1.6m2.0m1.7m1.5m1.1m1.2m2.1m3.1m

Preferred Stock

9.09.09.09.09.06.0

Additional Paid-in Capital

53.0m55.9m55.9m56.0m57.6m57.7m57.7m76.7m76.5m76.5m78.2m79.4m80.9m81.6m82.1m85.5m86.1m86.4m

Retained Earnings

(53.9m)(55.2m)(56.2m)(56.2m)(57.7m)(56.9m)(58.0m)(59.8m)(61.2m)(62.3m)(64.2m)(65.9m)(67.6m)(69.0m)(70.7m)(73.8m)(76.9m)(78.4m)

Total Equity

756.8k(278.7k)16.9m15.4m14.2m14.0m13.4m13.3m12.6m11.5m11.8m9.2m8.1m

Financial Leverage

3.6 x-9.5 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.2 x1.4 x

BIO-key International Cash Flow

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2018

Net Income

(2.6m)(4.2m)(6.9m)

Depreciation and Amortization

28.6k56.6k49.0k100.2k

Accounts Receivable

(2.8m)(241.8k)1.3m

Inventories

(5.2k)(336.8k)(296.8k)(52.0k)

Accounts Payable

(480.4k)811.2k(691.7k)(18.0k)

Cash From Operating Activities

(2.7m)(15.6m)(4.4m)(1.6m)

Cash From Investing Activities

(129.4k)(3.4k)(53.0k)(82.5k)

Cash From Financing Activities

4.8m19.0m1.2m1.7m

Interest Paid

77.2k100.0k

Free Cash Flow

(2.8m)(15.6m)(4.5m)(1.7m)

BIO-key International Ratios

USDY, 2019

Financial Leverage

1.4 x